Nippon Genetics and Bulldog Bio Create Alliance in North America
News Jul 18, 2013
Nippon Genetics Europe GmbH and Bulldog Bio have penned an agreement that assigns Bulldog Bio the sole right to sell many of Nippon Genetics’ electrophoresis and cell biology products to researchers in the USA.
Bulldog Bio in return will support, market, and stock their products.
“We’ve already seen early success with researchers adopting Nippon Genetics’ safe alternative to ethidium bromide which we began to sell early in the year.”
Ella Fontaine VP of Communications further elaborates “The feedback from many customers regarding Nippon Genetics wonderful line up of products has convinced us that there are many more labs that can benefit from these novel tools.”
The terms of this exclusive distribution contract have not been disclosed.
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE